International Stem Cell Corp. (ISCO) 股价表现
查看International Stem Cell Corp.股价及公司表现,包括市值,涨跌幅,市盈率,以及历史及当前股价。
昨收 0.20
52周最高 0.27
今开 0.20
52周最低 0.05
振幅 18.24%
市盈率 0%
成交额
0.00
亿
市净率 -0.32%
换手率 0.05%
总市值
0.00亿
股息 0
总股本
0.08
亿
股息收益率 0%
每手股数 1
International Stem Cell Corp.公司介绍
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenetic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial backgrounds, with minimal immune rejection after transplantation. hpSCs offer the potential to create the first true stem cell bank, UniStemCell?. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology (www.lifelinecelltech.com), and stem cell-based skin care products through its subsidiary Lifeline Skin Care (www.lifelineskincare.com).